
National Association of Testing Authorities, Australia
Scope of Accreditation
Adoradum Genomics
Scope of Accreditation
Withdrawn 21 Feb 2023
Adoradum Genomics
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Molecular genetics - DNA sequencing | Extracted DNA | Sequenced DNA utilising massively parallel sequencing technologies |
ISO/IEC 17025 (2017)
Healthcare, Pharmaceutical and Media Products
|
|||
Service | Product | Determinant | Technique |
---|---|---|---|
Analysis in support of research | Extracted DNA | Impact of host and pathogenic variation on disease and treatment outcomes | Massively parallel sequencing (MPS) |
ISO/IEC 17025 (2017) and ISO 15189 (2012) interpreted for research (2)
Healthcare, Pharmaceutical and Media Products
|
||||
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Conduct of research into host and pathogenic variation | Human biological samples - Clinical research studiesExtracted DNA | Impact on disease and treatment outcomes | DNA sequencing | Documented in house procedures |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20502
Site No.
24560
Print date
30 Nov 2023
END OF SCOPE